Department of Reproductive Medicine, John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK.
Department of Paediatric Oncology and Haematology, John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK.
Clin Endocrinol (Oxf). 2019 Aug;91(2):237-244. doi: 10.1111/cen.13994. Epub 2019 May 2.
Discordance between gonadal type and gender identity has often led to an assumption of infertility in patients with differences in sex development (DSD). However, there is now greater recognition of fertility being an important issue for this group of patients. Currently, gonadal tissue that may have fertility potential is not being stored for individuals with DSD and, where gonadectomy forms part of management, is often discarded. The area of fertility preservation has been predominantly driven by oncofertility which is a field dedicated to preserving the fertility of patients undergoing gonadotoxic cancer treatment. The use of fertility preservation techniques could be expanded to include individuals with DSD where functioning gonads are present.
This is a systematic literature review evaluating original research articles and relevant reviews between 1974 and 2018 addressing DSD and fertility, in vitro maturation of sperm, and histological/ultrastructural assessment of gonadal tissue in complete and partial androgen insensitivity syndrome, 17β-hydroxysteroid dehydrogenase type 3 and 5α-reductase deficiency.
Successful clinical outcomes of ovarian tissue cryopreservation are paving the way for similar research being conducted using testicular tissue and sperm. There have been promising results from both animal and human studies leading to cryopreservation of testicular tissue now being offered to boys prior to cancer treatment. Although data are limited, there is evidence to suggest the presence of reproductive potential in the gonads of some individuals with DSD. Larger, more detailed studies are required, but if these continue to be encouraging, individuals with DSD should be given the same information, opportunities and access to fertility preservation as other patient groups.
在性发育障碍(DSD)患者中,性腺类型与性别认同之间的差异常常导致人们假设其不育。然而,现在人们越来越认识到生育能力是这群患者的一个重要问题。目前,对于 DSD 患者,可能具有生育潜力的性腺组织没有被储存,而在性腺切除术成为治疗手段的情况下,这些组织通常被丢弃。生育力保存领域主要由肿瘤生育力驱动,该领域致力于保存接受性腺毒性癌症治疗的患者的生育能力。生育力保存技术的使用范围可以扩大到存在功能性性腺的 DSD 患者。
这是一项系统文献综述,评估了 1974 年至 2018 年间涉及 DSD 和生育力、精子体外成熟以及完全和部分雄激素不敏感综合征、17β-羟类固醇脱氢酶 3 型和 5α-还原酶缺乏症中性腺组织的组织学/超微结构评估的原始研究文章和相关综述。
卵巢组织冷冻保存的成功临床结果为使用睾丸组织和精子进行类似的研究铺平了道路。动物和人体研究都取得了有希望的结果,导致现在在癌症治疗前向男孩提供睾丸组织冷冻保存。尽管数据有限,但有证据表明,一些 DSD 患者的性腺具有生殖潜力。需要进行更大、更详细的研究,但如果这些研究继续令人鼓舞,那么 DSD 患者应该像其他患者群体一样,获得相同的生育力保存信息、机会和途径。